RESP (Respiratory Expert Speaker and Patient) webinar series 

 

Discover the future of Lung Cancer detection in the latest RESP seminar. 

 

Wednesday 3 September, 7-8pm via Teams 

 

This insightful and educational session is part of the RESP (Respiratory Expert Speaker and Patient) webinar series, proudly presented by Respiratory Futures, INSPIRE and Asthma + Lung UK. 

 

This webinar will feature expert speaker Professor Sam Janes and a patient representative. 

 

Book your space here 

 

What they will cover: 

Current Lung Cancer detection strategies 

Future directions based on the latest research 

Expert patient insights 

 

 

This webinar is RCP CPD approved (code: 151141) for those who join the live webinar and complete the feedback form provided. Please note: Application for CPD approval has been submitted to the Federation of the Royal Colleges of Physicians of the UK. 

 

Sam is the Director of Medicine at University College London, a division within the Faculty of Medical Sciences that encompasses 8 departments, over 20 centres and around 130 principal investigators across three campuses. His laboratory research, funded by Medical Research Council and Cancer Research UK programme grants focusses on the airways and examines both normal homeostasis and the earliest development of cancer. 

 

Major contributions include defining that normal airway homeostasis is governed by stochastic division of basal cell; showing that airways genetically damaged by smoking can resolve on quitting; mapping the molecular architecture of pre-cancerous Squamous cell lesions, and identifying the immunological abnormalities that allow precancerous lesions to progress to cancer. These achievements were recognised with his election to the Academy of Medical Sciences in 2021. 

 

He is the chief investigator of several trials ranging first-in-man trials of cell and gene therapies emanating from his own lab, to SUMMIT, the largest lung cancer screening trial in Europe recruiting over 13000 people. He works across the University, UCL Hospitals, the UCLH Biomedical Research Centre and interacts closely with industry, again ranging from trial delivery through to venture capital funded drug discovery programmes. 

 

He works as a respiratory consultant at UCLH with a particular interest in lung cancer, mesothelioma, interventional and diagnostic bronchoscopy and early lung cancer detection. He has been Head of UCL Respiratory, Vice-Chair of the National ‘Clinical Expert Group’ on Lung Cancer and the Faculty of Medical Science Vice-Dean of Research at UCL. 

What they covered: 

Latest research and current management strategies in CF 

 

Dr Charlotte Addy is a specialist in Cystic Fibrosis working at the All Wales Adult Cystic Fibrosis (CF) Centre is based at University Hospital Llandough. She is a member of the British Thoracic Society council, previously working on the Workforce and Service Development Committee. She has a special interest in medical education, workforce planning and clinical research. 

 

 

What they covered: 

New evidence in management of primary and secondary pneumothorax 

Patient experience of pneumothorax 

 

Dr Steve Walker is an NIHR Consultant Senior Lecturer in Respiratory Medicine with a specialist interest in pleural disease. He is co-chair of the ERS Pleural Clinical Research Collaborations group. 

 

 

 

Current COPD management strategies 

Future directions based on the latest research 

 

Meet the Speaker 

Professor Mona Bafadhel is the Chair of the BTS Science and Research Committee. She is the Director of the new King’s Centre for Lung Health, and the Chair of Respiratory Medicine at King’s College London. 

 

She is a consultant respiratory physician with a clinical and research interest in chronic obstructive lung disease (COPD) and asthma. Mona is an international academic leader in respiratory medicine, with a passion for translating science to clinical practice to improve outcomes for patients. 

What they covered: 

Health technologies for COPD 

Patient impact 

 

Meet the Speakers 

 

Professor Hart is currently Deputy Medical Director of the Heart, Lung and Critical Care Clinical Group. Previously, he directed the critical care response to the COVID-19 pandemic as the primary respiratory physician to Prime Minister Boris Johnson. A leading researcher in chronic respiratory disease and mechanical ventilation, he has established the Lane Fox Clinical Respiratory Physiology Research Centre and PhD programme, as well as serving as Joint Editor-in-Chief of Thorax. He was awarded the BTS Meritorious Service Award (2022) and is the Respiratory Theme Lead for the Guy’s & St Thomas’ NIHR Cardiorespiratory Healthtech Research Centre. 

 

Chantal Davies was diagnosed with COPD/emphysema in 2010 following 11 weeks being intubated and a lengthy time in ICU. During her rehabilitation, she joined Professor Hart on his team as a Public Patient representative at Lane Fox, St Thomas' hospital. Chantal describes the experience as meaningful as "it was my way of giving back to the NHS for all the great care I had had, and there was the hope that there would be future treatments for my condition." She is now in her eleventh year as a PPI member, not only for Lane Fox but for other Hospitals and Universities in the UK and has taken part in numerous clinical trials and studies such as March Trial, Delta ICU, EpiC-HPT and NAVA.it.